At a glance
ClinicalIndex Comparison RecordN/ACompleted· 140 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Influence of Noradrenergic Activity on Attentional Control in Younger and Older Adults
In Brief
An observational study for Aging. Completed, enrolled 140 participants across 1 site.
Detailed Summary
Older adults demonstrate increased distractibility by task-irrelevant information which contributes to general cognitive impairment. However, it is yet unclear how changes in noradrenergic activity during aging influences attentional control. In the current study, tonic noradrenergic activity will be increased or decreased to investigate its behavioral and neural effects on attentional control.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAging
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartNov 2021
First PostedNov 2021
Primary CompletionNov 2023
TodayJul 2026
First PostedNov 15, 2021
Enrollment StartNov 1, 2021
Primary CompletionNov 20, 2023
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 4.6 years ago